|
| 37072105 | Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results. | J Card Fail | 2024 |
| 37715769 | Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-Reduced. | JACC Heart Fail | 2024 |
| 37952176 | Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial. | JAMA Cardiol | 2024 |
| 37950893 | Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis. | Circulation | 2024 |
| 37897459 | Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure. | JACC Heart Fail | 2024 |
| 37942588 | Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors. | Eur Heart J Cardiovasc Pharmacother | 2024 |
| 37578188 | Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. | Diabet Med | 2024 |
| 37985002 | Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial. | ESC Heart Fail | 2024 |
| 37820896 | Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial. | J Card Fail | 2024 |
| 37767674 | Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial. | JACC Heart Fail | 2024 |
| 36342789 | Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER. | Circulation | 2023 |
| 37634707 | Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function. | J Am Coll Cardiol | 2023 |
| 37634087 | Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER. | Eur J Heart Fail | 2023 |
| 37632711 | Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial. | Eur J Heart Fail | 2023 |
| 37632455 | Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. | Circulation | 2023 |
| 37712339 | Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. | Eur J Heart Fail | 2023 |
| 37905361 | Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure. | Eur J Heart Fail | 2023 |
| 37750584 | Development and Phenotype of Heart Failure in Long-Term Survivors of Childhood Cancer: The CVSS Study. | J Am Heart Assoc | 2023 |
| 37622666 | 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. | Eur Heart J | 2023 |
| 37655679 | Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial. | Eur J Heart Fail | 2023 |
| 37614542 | Association Between Diabetes, Chronic Kidney Disease, and Outcomes in People With Heart Failure From Asia. | JACC Asia | 2023 |
| 37889197 | Acute Heart Failure Is a Malignant Process: But We Can Induce Remission. | J Am Heart Assoc | 2023 |
| 37886880 | Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. | Circ Heart Fail | 2023 |
| 37691140 | Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF model. | Eur J Heart Fail | 2023 |
| 37649316 | Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. | ESC Heart Fail | 2023 |
| 37648271 | Countering sex and gender bias in cardiovascular research requires more than equal recruitment and sex disaggregated analyses. | BMJ | 2023 |
| 37610398 | Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure. | J Am Coll Cardiol | 2023 |
| 37503602 | Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat. | Circ Heart Fail | 2023 |
| 37940229 | Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. | J Am Coll Cardiol | 2023 |
| 37830208 | Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial. | Circulation | 2023 |
| 37771274 | Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial. | Eur J Heart Fail | 2023 |
| 37771260 | Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. | Eur J Heart Fail | 2023 |
| 37728038 | Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trial. | Eur J Heart Fail | 2023 |
| 37678961 | Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. | JACC Heart Fail | 2023 |
| 38095008 | Clinical Features of Heart Failure With Normal Ejection Fraction: Insights From the ASIAN-HF Registry. | JACC Asia | 2023 |
| 38094996 | Asia-Pacific Investigators and Asian Enrollment in Cardiometabolic Trials: Insights From Publications Between 2011 and 2020. | JACC Asia | 2023 |
| 38094687 | The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF. | JACC Basic Transl Sci | 2023 |
| 37814060 | Recent successes in heart failure treatment. | Nat Med | 2023 |
| 37567750 | Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF. | BMJ Open | 2023 |
| 37565977 | Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction. | JACC Heart Fail | 2023 |
| 37565973 | Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial. | JACC Heart Fail | 2023 |
| 37532426 | Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3. | J Am Coll Cardiol | 2023 |
| 37257948 | Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction. | J Am Coll Cardiol | 2023 |
| 37220823 | Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial. | J Card Fail | 2023 |
| 37220822 | Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER. | Am Heart J | 2023 |
| 37323861 | Patient-Reported Status and Heart Failure Outcomes in Asia by Sex, Ethnicity, and Socioeconomic Status. | JACC Asia | 2023 |
| 37220172 | Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER. | Eur Heart J | 2023 |
| 37220093 | Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial. | Eur Heart J | 2023 |
| 37191154 | Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial. | Eur J Heart Fail | 2023 |
| 37350280 | Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation. | Circ Heart Fail | 2023 |